One study demonstrated that the inflammatory pathways associated with obesity are regulated by liver-derived DPP4, so targeting DPP4 expression could be sufficient to prevent WAT inflammation and insulin resistance [109]. The gene discussed is DPP4; the disease is Insulin resistance.